Armata Pharmaceuticals, Inc. — Director's Dealing 2017

Sep 11, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AmpliPhi Biosciences Corp (APHB)
CIK: 0000921114
Period of Report: 2017-09-07

Reporting Person: GRINT PAUL C (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-09-07	Stock Option (Right to Buy)	$0.91	A	190076	Acquired	2027-09-06	Common Stock (190076)	Direct
2017-09-07	Stock Option (Right to Buy)	$0.91	A	285113	Acquired	2027-09-06	Common Stock (285113)	Direct

Footnotes

F1: 1/4th of the shares subject to the option vest on September 7, 2018. The remainder of the shares vest in equal monthly installments thereafter over the next three years.

F2: 100% of the shares subject to the stock option shall vest and become exercisable on September 5, 2027, subject to earlier vesting upon the satisfaction of performance criteria.